© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
High quantities of aberrantly expressed genes are predictive of tumor aggressiveness and poor oncologic outcomes in patients with clear cell renal cell carcinoma, according to a recent study.